Rein Therapeutics, Inc. Cash and Cash Equivalents
Rein Therapeutics, Inc. (RNTX) had Cash and Cash Equivalents of $8.54 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-14
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $8.54M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $4.45M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $3.21M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $4.05M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $8.54M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $4.45M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $3.21M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $4.05M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $5.72M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $7.43M 10-Q · filed 2026-05-15 | |
| 2024-12-31 | $12.87M 10-Q · filed 2026-05-15 | |
| 2024-09-30 | $17.65M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $21.92M 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $12.04M 10-Q · filed 2025-05-15 | |
| 2023-12-31 | $17.34M 10-K · filed 2026-03-26 | $17.31M 10-K · filed 2024-04-15 |
| 2023-09-30 | $12.07M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $13.17M 10-Q · filed 2024-08-14 | |
| 2023-03-31 | $7.78M 10-Q · filed 2024-05-15 | |
| 2022-12-31 | $5.19M 10-K · filed 2024-04-15 | |
| 2022-09-30 | $4.84M 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $7.63M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $7.45M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $3.60M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $7.60M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $10.75M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $19.28M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $7.05M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $7.85M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $17.12M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $10.70M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $5.31M 10-K · filed 2021-03-24 | |
| 2019-09-30 | $6.87M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $10.16M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $11.27M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $10.63M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $7.72M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $11.98M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $6.78M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $11.86M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $13.43M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $9.40M 10-Q · filed 2017-08-10 | |
| 2016-12-31 | $20.71M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $4.50M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $3.88M 10-Q · filed 2017-08-10 | |
| 2015-12-31 | $3.77M 10-K · filed 2018-04-02 | |
| 2014-12-31 | $6.21M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |